Assembly Biosciences
ASMB
105 hedge funds and large institutions have $640M invested in Assembly Biosciences in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 30 reducing their positions, and 18 closing their positions.
199% more call options, than puts
Call options by funds: $12.7M | Put options by funds: $4.24M
53% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 30
0.13% more ownership
Funds ownership: 6.61% → 6.74% (+0.13%)
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
2% less funds holding
Funds holding: 107 → 105 (-2)
19% less capital invested
Capital invested by funds: $789M → $640M (-$149M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$10.7M |
| 2 |
BlackRock
New York
|
+$7.19M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.65M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$4.07M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$3.75M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$14.4M |
| 2 |
AC
Armistice Capital
New York
|
-$6.29M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$5.75M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.04M |
| 5 |
Renaissance Technologies
New York
|
-$2.3M |
ASMB Hedge Fund Activity: Q2 2018 in Review
105 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2018, worth a combined $640M — down 19% from $789M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of ASMB and 17 opened new positions — a net loss of 1 holder — while 30 trimmed existing stakes and 46 added.
The largest buyer was Janus Henderson Group, adding an estimated $10.7M. The largest seller was Perceptive Advisors, cutting an estimated $14.4M.
- 105 institutional investors held Assembly Biosciences (ASMB) as of Q2 2018, down from 107 in Q1 2018.
- Funds reported $640M of Assembly Biosciences stock for Q2 2018, down 19% quarter-over-quarter.
- 17 funds opened new Assembly Biosciences positions in Q2 2018 and 18 closed out, a net change of -1 holder.
- The largest Assembly Biosciences buyer in Q2 2018 was Janus Henderson Group, an estimated $10.7M added.
- The largest Assembly Biosciences seller in Q2 2018 was Perceptive Advisors, an estimated $14.4M sold.
Based on aggregated 13F filings for Q2 2018.